You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
They have begun clinical testing of a table-top centrifuge and microfluidic chip that efficiently separated exosomes and enabled testing for disease markers in an internal study.
The researchers said that their reagent, which makes TB cells emit light, could be integrated into slide-and-microscope testing platforms.
The researchers said that a study to validate their concept showed that the platform has potential to detect cancer and infectious disease biomarkers in human blood.
The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.
The device is an electrochemical lateral flow immunosensor test that will initially be used to detect dengue hemorrhagic fever, and later, to assess stroke severity.
A broad team of researchers has developed a microarray that looks for 171,000 different peptide fragments to differentiate among tick-borne diseases.
The test would also be used to detect antibiotic susceptibility. Fraunhofer received £900,000 from SBRI Healthcare in support of the project to develop the test.
In a first clinical tryout, University of Turku researchers have shown that their assay has sensitivity and specificity levels on par with those of laboratory ELISAs.
Three independent studies have shown that an α-synuclein assay technology detected early Parkinson's with high levels of sensitivity and specificity.
Neurovascular Diagnostics intends to commercialize a test for unruptured intracranial aneurysm tests that use RNA expression signatures.